Clark MA, Hartley A, Geh JI (2004) Cancer of the anal canal. Lancet Oncol 5:149–157
International Agency for Research on Cancer. Global Cancer Observatory : Cancer Today. https://gco.iarc.fr/today/fact-sheets-populations. Accessed 3 Dec 2021.
Yamada K, Saiki Y, Komori K et al (2022) Characteristics of anal canal cancer in Japan. Cancer Med 11:2735–2743
Article PubMed PubMed Central Google Scholar
Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” (Easy R) for medical statistics. Bone Marrow Transplant 48:452–458
Article CAS PubMed Google Scholar
Digestive System Tumours (2017). In: Brierley JD, Gospodarowicz MK, Wittekind C (eds) TNM classification of Malignant Tumours, 8th edition(UICC). Wiley, Blackwell, pp 55–103
Upper Gastrointestinal Tract (2017) Lower Gastrointestinal Tract and Hepatobiliary System. In: Amin MB (ed) AJCC Cancer Staging Manual, 8th edn. Springer, pp 185–347
Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma, 9th Japanese edition. Kanehara & Co., Ltd, 2018
National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. Cancer Stat Facts: Anus, Anal Canal, and Anorectum. Bethesda, MD: National Cancer Institute; 2024. https://seer.cancer.gov/statfacts/html/anus.html Accessed 21 Oct 2025.
Cancer research UK: Anal Cancer Statistics https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/anal-cancer Accessed October 21, 2025.
Bruni L, Albero G, Serrano B, et al. Human Papillomavirus and Related Diseases Report: Japan. ICO/IARC HPV Information Centre; 2023. https://hpvcentre.net/statistics/reports/JPN_FS.pdf Accessed October 21, 2025.
Klas JV, Rothenberger DA, Wong WD et al (1999) Malignant tumors of the anal canal. The spectrum of disease, treatment, and outcomes. Cancer 85:1686–1693
Article CAS PubMed Google Scholar
Johnson LG, Madeleine MM, Newcomer LM et al (2004) Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973–2000. Cancer 101:281–288
Joseph DA, Miller JW, Wu X et al (2008) Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer 113:2892–2900
Brewster DH, Bhatti LA (2006) Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975–2002. Br J Cancer 95:87–90
Article CAS PubMed PubMed Central Google Scholar
Nielsen A, Munk C, Kjaer SK (2012) Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978-2008. Int J Cancer 130:1168–1173
Article CAS PubMed Google Scholar
Jin F, Stein AN, Conway EL et al (2011) Trends in anal cancer in Australia, 1982–2005. Vaccine 29:2322–2327
Sumikoshi Y (1982) Multi-institutional registration of anal cancer in Japan. J Jpn Soc Coloproctol 35:92–97
Sameshima S, Sawada T, Nagasako K (2005) Squamous cell carcinoma of anus and carcinoma in association with anal fistula in Japan. J Jpn Soc Coloproctol 58:415–421
Boman BM, Moertel CG, O’Connell MJ et al (1984) Carcinoma of the anal canal A clinical and pathologic study of 188 cases. Cancer 54(1):114–125
Article CAS PubMed Google Scholar
Nigro ND (1984) An evaluation of combined therapy for squamous cell cancer of the anal canal. Dis Colon Rectum 27:763–766
Article CAS PubMed Google Scholar
National Comprehensive Cancer Network. Anal carcinoma. Version 4. 2025. https://www.nccn.org/professionals/physician_gls/pdf/anal.pdf.Accessed 21 Oct 2025.
Yamada K, Shiraishi K, Takashima A et al (2023) Characteristics of anal canal squamous cell carcinoma as an HPV-associated cancer in Japan. Int J Clin Oncol 28:990–998
Daling JR, Madeleine MM, Johnson LG et al (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101:270–280
Frisch M, Glimelius B, van den Brule AJ et al (1997) transmitted infection as a cause of anal cancer. N Engl J Med 337:1350–1358
Article CAS PubMed Google Scholar
Jimenez W, Paszat L, Kupets R et al (2009) Presumed previous human papillomavirus related gynecological cancer in women diagnosed with anal cancer in the province of Ontario. Gynecol Oncol 114:395–398
Ryan DP, Compton CC, Mayer RJ (2000) Carcinoma of the anal canal. N Engl J Med 342:792–800
Article CAS PubMed Google Scholar
Sunesen KG, Norgaard M, Thorlacius-Ussing O et al (2010) Immunosuppressive disorders and risk of anal squamous cell carcinoma: a nationwide cohort study in Denmark 1978-2005. Int J Cancer 127:675–684
Article CAS PubMed Google Scholar
Frisch M, Biggae RJ, Goedert JJ (2000) Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92:1500–1510
Article CAS PubMed Google Scholar
Uronis HE, Bendell JC (2007) Anal cancer: an overview. Oncologist 12:524–534
Alemany L, Saunier M, Alvarado-Cabrero I et al (2015) HPV DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer 136(1):98–107
Article CAS PubMed Google Scholar
Herfs M, Roncarati P, Koopmansch B et al (2018) A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine. Br J Cancer 118:1302–1312
Article CAS PubMed PubMed Central Google Scholar
Uchino M, Ikeuchi H, Hata K et al (2021) Intestinal cancer in patients with Crohn’s disease: a systematic review and meta-analysis. J Gastroenterol Hepatol 36(2):329–336
Ogino T, Mizushima T, Fujii M et al (2023) Crohn’s disease-associated anorectal cancer has a poor prognosis with high local recurrence: A subanalysis of the nationwide Japanese study. Am J Gastroenterol 118(9):1626–1637
Article CAS PubMed PubMed Central Google Scholar
Lu C, Schardey J, Zhang T et al (2022) Survival outcomes and clinicopathological features in inflammatory bowel disease-associated colorectal cancer: a systematic review and meta-analysis. Ann Surg 276(5):e319–e330
Connell RW, Sheffield PJ, Kamm AM et al (1994) Lower gastrointestinal malignancy in Crohn’s disease. Gut 35(3):347–352
Article CAS PubMed PubMed Central Google Scholar
Takashima A, Shimada Y, Hamaguchi T et al (2009) Current therapeutic strategies for anal squamous cell carcinoma in Japan. Int J Clin Oncol 14:416–420
Murofushi K, Itasaka S, Shimokawa M et al (2022) A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10-2 trial). J Radiat Res 64(1):154–161
Article PubMed Central Google Scholar
Ito Y, Hamaguchi T, Takashima A et al (2023) Definitive S-1/mitomycin-C chemoradiotherapy for stage II/III anal canal squamous cell carcinoma: a phase I/II dose-finding and single-arm confirmatory study (JCOG0903). Int J Clin Oncol 28:1063–1072
Comments (0)